Cytosorbents Corp (CTSO) stock
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$5.37+0.03 (+0.56%)
Close on Nov 12, 2026Market cap $337.47MP/E –Yield –
Cytosorbents enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cytosorbents's enterprise value was $348.41M on Nov 11, 2026, against $1.03B a year earlier. Over the last 5 years it ranged from $257.91M to $3.58B, with a median of $1.14B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $348.41M | -57.0% |
| 2025 | Dec 31, 2025 | $809.79M | -18.5% |
| 2024 | Dec 31, 2024 | $993.55M | +2.6% |
| 2023 | Dec 29, 2023 | $968.49M | -27.1% |
| 2022 | Dec 30, 2022 | $1.33B | -62.9% |
| 2021 | Dec 31, 2021 | $3.58B | -47.4% |
| 2020 | Dec 31, 2020 | $6.81B | +172.9% |
| 2019 | Dec 31, 2019 | $2.50B | -51.0% |
| 2018 | Dec 31, 2018 | $5.10B | +37.9% |
| 2017 | Dec 29, 2017 | $3.70B | +33.2% |
| 2016 | Dec 30, 2016 | $2.77B | -0.7% |
| 2015 | Dec 31, 2015 | $2.80B | +9.1% |
| 2014 | Dec 31, 2014 | $2.56B | +319.6% |
| 2013 | Dec 31, 2013 | $610.50M | +12.3% |
| 2012 | Dec 31, 2012 | $543.67M | -1.0% |
| 2011 | Dec 30, 2011 | $549.01M | – |
See a number that looks wrong?